Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.
Deverra Therapeutics has raised $972K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in September 2024.
Deverra Therapeutics's investors include 5AM Ventures, Andy Hill Cancer Research Endowment (CARE) Fund.
Deverra Therapeutics is headquartered in Seattle, United States.
Deverra Therapeutics is a biotechnology company that develops allogeneic cellular immunotherapies.
Deverra Therapeutics is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deverra Therapeutics — Funding & Investors." VCBacked, September 4, 2024, https://www.vcbacked.co/company/deverra-therapeutics. Accessed August 13, 2026.
VCBacked. (2024). Deverra Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/deverra-therapeutics
{{cite web |title=Deverra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/deverra-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated